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ABSTRACT 
Objective: To identify various drug related problems in patients admitted to the general ward of a tertiary care hospital and to make suitable drug 
therapy recommendations. 
Methods: A prospective observational study was conducted in the Annex General ward in B Block of Amrita Institute of Medical Sciences, Kochi for 
a period of 6 months. All the patients admitted to the general ward on particular day of each week and who satisfied the selection criteria were 
included in this study. 
Results: During the study period, a total of 598 drug related problems were identified of which 55.51% were due to prescribing of interacting drugs 
followed by drug choice problems (12.71%). Three hundred and thirty two drug interactions were observed in 224 patients. Thirty nine adverse 
drug reactions were observed in the study patients and cardiac drugs were the main class of drugs involved. Eighty seven drug interventions were 
done in 224 patients. It took an average of 25-35 minutes per intervention. Out of the total 87 interventions made, 41.4% (36) were at the 
prescriber level followed by 30% (27) at drug administration level. 23% of drug interventions were made at the patient level. 88.5% of the 
interventions were accepted and 11.5% were rejected. 
Conclusion: This study shows the positive impact of clinical pharmacists in identification and resolution of drug related problems in a tertiary care 
hospital. 
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INTRODUCTION 
Patient safety is one of the most important aspects of health care 
system. Medicines can cure illness and at the same time harm the 
patient if not appropriately used. Hence every patient must receive 
the right medication, in the right amount and at the right time [1]. 
Drug induced morbidity has become a common problem [2]. Drug 
related problem (DRP) is a broad term as it includes problems 
related to the drug at any level of use i.e. at the prescribing level, 
dispensing level, administration level or at the patient or carer level. 
Adverse reactions to a drug (ADR), allergic reactions, drug not 
prescribed appropriately, drug prescribed not appropriate for 
indication, indication for which no drug is prescribed, 
contraindicated drug prescribed, duplication of drug therapy, 
administration and storage errors, inappropriate laboratory and 
non-laboratory monitoring, drug interactions, medical chart errors, 
patient noncompliance and unawareness about the usage of drugs 
etc. are some examples of DRPs [3]. 
Drug related problems can be classified as per different classification 
systems. These include American Society of Hospital Pharmacists 
(ASHP) System, Cipolle et al., Granada consensus, Hepler/Strand, 
Pharmaceutical Care Network Europe (PCNE) classification, 
Problem-Intervention Documentation (PI-oc), and Westerlund 
classification [4]. World Health Organisation (WHO) defines ADRs as 
any response to a drug which is noxious, unintended and which 
occur at doses normally used in man for prophylaxis, diagnosis, or 
therapy of diseases, or for the modification of physiological function 
[5]. Previous studies indicated that ADRs account for 5% of all 
hospital admissions and occur in 10-20% of hospitalized patients 
[6]. Prescription errors include prescription of a wrong drug for an 
indication, prescribing a contraindicated drug, prescribing 
interacting drugs together, prescribing a wrong dose or dosage form 
[7]. Clinical pharmacist can play a key role in promoting better 
medication use, ensuring that patients receive appropriate 
pharmacotherapy thus minimizing the risk of unfavourable 
outcomes of pharmacotherapy [8]. There are only few reported 
studies from India regarding drug related problems in a tertiary care 
hospital and the involvement of clinical pharmacists in overcoming 
these errors. [9-12]. The aim of the present study was to explore the 
various drug related problems that occur in patients admitted to the 
general ward of a tertiary care hospital and to make suitable drug 
therapy recommendations. 
MATERIALS AND METHODS 
A prospective observational study was conducted in the Annex 
General ward in B Block of Amrita Institute of Medical Sciences 
(AIMS), Kochi for a period of 6 months from September 2011 to 
February 2012. Ethical clearance for the study was obtained from the 
Institutional Review Board. Annex General ward has separate male 
and female sections with a total bed capacity of 120. Patients of 
various specialties like Nephrology, General Medicine, 
Gastroenterology, Neurology, Endocrinology, Oncology, 
Rheumatology, Pulmonary Medicine and Dermatology are admitted to 
this ward. On an average 15 new patients are admitted to the ward on 
a daily basis with an average daily bed occupancy rate of 92.5%. 
All the patients admitted to general ward on the day of sampling 
were included in the study while patients admitted on days other 
than sampling day were excluded from the study. Similarly patients 
unwilling to provide informed signed consent were excluded from 
the study. Sampling was done on a weekly basis. i.e. In the first week 
of study all the patients admitted to the general ward on Sunday 
were selected and were followed up till they were discharged. In the 
second week all patients admitted to the ward on Monday were 
selected and followed up till they were discharged. Likewise 
sampling was done on subsequent days of the consecutive weeks for 
the duration of the study. Patient data were collected using 
standardized data collection form, drug related problem check list 
and pharmaceutical care intervention documentation form. DRPs 
were classified as per PCNE classification system [13]. Severity of 
the drug interactions were classified as per Uptodate® drug 
interaction [14] checker whereas modified Hartwig and Sagel scale 
[15] was used to assess the severity of the ADRs. 
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RESULTS AND DISCUSSION 
A total of 224 patients were included in the study based on the 
inclusion and exclusion criteria out of which 133 patients were 
males (59.4%) with a mean age of 59.2±14.7 years and 91 patients 
were females (40.6%) with a mean age of 41.3±12.5 years. A similar 
prospective observational and interventional study conducted by 
Ganachari et al. [10] from Belgum, India also reported male 
(58.06%) predominance over females (41.93%).  
Maximum number of patients were in the age group of 55-65 years 
(22.77%) followed by 45-55 (21.88%) years. Patients from the 
general medicine department (32.59%) were maximum followed by 
gastroenterology (25%). Out of the 2264 drugs prescribed, 1175 
(78.4%) were branded drugs and 489 (21.6%) were generic drugs. 
Prescribing by generic name should be followed as it can reduce 
confusion among the pharmacists while dispensing. It also helps in 
cost minimization. For the comparison of brand vs. generic 
prescribing their proportions were compared using ‘Z test’. 
Percentage of patients prescribed branded drugs was significantly 
higher than the percentage of patients prescribed generic drugs 
(p<0.001). An average of 10.1 drugs was prescribed per admitted 
patient. Mean duration of hospital stay of patients was 6.06±3.44 
days. Majority of the patients received a total of 12 drugs during the 
hospital stay. 24.43% of total drugs prescribed were gastrointestinal 
and hepatobiliary drugs followed by cardiac drugs (15.37%), anti-
infective drugs (14.97%), central nervous system drugs (10.56%) 
etc. Among the 224 patients in the study sample 70.54% (158) 
patients were prescribed antibiotics. 41.14% of the 158 patients 
were prescribed with only one antibiotic. Majority of patients were 
prescribed with more than one antibiotic (table 1). 
 
Table 1: Percentage of patients prescribed antibiotics during 
the hospital stay (n=224) 
No. of antibiotics prescribed per patient No. (%) of patients 
1 65 (41.14) 
2 48 (30.38) 
3 25(15.82) 
4 18 (11.39) 
5 1 (0.63) 
6 1(0.63) 
 
A total of 598 drug related problems were identified from 224 study 
patients (table 2). An average of 2.83±2.74 DRPs occurred per 
patient.  
169 patients (75.5%) in the study sample had at least one DRP and 
55 patients (24.5%) had no DRPs. 332 of these DRPs were due to 
prescribing of interacting drugs. Out of the 169 patients who had 
DRPs 97 were males and 72 were females with a mean age of 
59.4±15 years and 40.2±12.6 years respectively. Patient or provider 
related problems were the least identified DRPs. Patient or provider 
related problems include over use or under use of drug by the 
patient, non-adherence of the patient etc. As this study was 
conducted on inpatients this will not be significant because drugs 
were administered to the patients by the nurse or bystander at the 
prescribed time. So there was proper administration of patient’s 
medications to a great extent. 
 
Table 2: Drug related problems identified in the study patients 
as per PCNE V5 classification (n=598) 
Types of DRPs Frequency Percentage 
Adverse drug reactions 39 6.6 
Drug choice problems 76 12.8 
Dosing problems 17 2.9 
Drug use problems 50 8.3 
Drug interactions 332 55.5 
Laboratory and non-laboratory 
monitoring problems 
32 5.3 
Patient or provider related problems 7 1.1 
Medical chart errors 45 7.53 
 
From table 3 it is evident that occurrence of DRPs was low in 
patients prescribed ≤ 4 drugs compared to patients prescribed ≥ 5 
drugs. As the number of drugs prescribed to a patient increases, the 
chance of interactions and errors also increases. Polypharmacy 
refers to the effect of taking multiple medications, mostly more than 
five medications, to manage co-existing health problems [16]. To test 
the effect of poly pharmacy on DRPs, proportional cases with ≤ 4 
drugs prescribed and ≥ 5 drugs prescribed we re compared using ‘Z 
test’. Proportional DRPs for patients prescribed ≤ 4 drugs was 
significantly lower than for patients prescribed ≥ 5 drugs (p<0.001). 
Hence polypharmacy should be avoided at all costs unless absolutely 
necessary such as when the patient has comorbid disorders, or when 
the drug combination results in a favourable interaction. 
Majority of patients with polypharmacy belonged to the age group of 
50-75 years. Cardiac drugs (23.24%) were the main class of drugs 
involved in DRPs followed by CNS drugs (19.06%) and anti-infective 
drugs (18.89%). In a study conductedin 3 medical wards of a public 
teaching hospital in India antimicrobials (29.4%) were the main 
class of drugs involved in medication errors followed by 
cardiovascular drugs (15.4%), GI agents (8.6%) and CNS agents 
(8.2%) [17]. In our study, among the 2264 drugs prescribed, 330 
drugs were involved in drug related problems. An average of 1.81 
DRPs occurred per drug. About 192 (58.18%) drugs caused more 
than one drug related problem per patient. 
 









Number of patients 
with 5-9 drugs 
prescribed* 
(n=70) 




Number of patients 
with 15-19 drugs 
prescribed* 
(n=27) 
Number of patients 
with 20-25 drugs 
prescribed* 
(n=10) 
0 DRP 19 21 12 2 1 
1DRP 8 13 14 3 - 
2 DRPs 6 18 15 3 1 
3 DRPs - 12 17 2 1 
4 DRPs - 3 11 2 2 
5 DRPs - - 9 4 - 
6 DRPs - 3 3 5 - 
7 DRPs - - 1 2 - 
8 DRPs - - - 1 2 
9 DRPs - - 1 - 2 
10DRPs - - 1 1 - 
>10 
DRPs 
- - - 2 1 
*Total number of drugs prescribed during the hospital stay of the patients 
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Fig. 1: DRPs observed in relation to polypharmacy (n=224) 
 
Drug interactions (55.51%) were the main type of DRPs identified. 
This may be because of the increased number of drug prescriptions 
to inpatients. An average of 10.11±4.74 drugs was prescribed per 
patient per admission. Some of these drug interactions were major 
(25.3%) which needed some intervention while some did not 
require any intervention, but had to be monitored for patient 
response. Interventions suggested for major drug interactions 
included reduction in dosage of one of the interacting drugs or 
substitution of the interacting drug with a non interacting drugs. A 
study conducted by Kumar et al. [17] in the medical wards of a 
public teaching hospital in India showed that drug interactions 
(68.2%) were the most frequently occurring type of DRPs. 
A total of 332 drug interactions were observed in 224 patients. Majority 
of drug interactions observed were of moderate severity (44.7%) 
followed by interactions of major significance (25.3%) and then minor 
significance (30%). Amiodarone+Simvastatin: Amiodarone inhibits 
CYP3A4 enzyme which is responsible for simvastatin metabolism and 
thereby increases risk of rhabdomyolysis and Phenytoin+Nifedipine: 
Phenytoin may decrease the level of calcium channel blockers (CCBs) by 
inducing CYP3A4 enzyme responsible for the metabolism of CCBs, were 
the major significant interactions identified. Moderately significant 
interactions included Methotrexate+Proton Pump inhibitors (PPIs) 
(concurrent use of methotrexate and PPIs may result in elevated levels of 
Methotrexate causing Methotrexate related toxicities), 
Ciprofloxacin+Prednisolone (concurrent use may increase the risk of 
tendinitis and tendon rapture associated with flouroquinolone 
treatment), Ciprofloxacin+Theophylline (co-administration with 
Ciprofloxacin will increase serum concentration of Theophylline) etc. 
Huysmans et al., in a report from Belgium [18] regarding drug related 
problems detected in community pharmacies, found that drug 
interactions were the main category of drug related problems.  
A total of 39 ADRs were observed in 224 patients with a mean age 
group of 51.18±17.35. A higher percentage of ADRs were found in 
males (69.4%) than in females (30.6%). Cardiac drugs (30.78%) 
were the main class of drugs involved in causing ADRs followed by 
genitourinary drugs (17.95) and anti-infective drugs (17.95%). 
 
Table 4: Classes of drugs involved in ADRs (n=39) 
Classes of drugs Frequency % of total drugs 
involved 
Cardiac drugs 12 30.78 
Genitourinary 7 17.95 
Anti-infective drugs 7 17.95 
CNS* 5  drugs 12.82 




Antineoplastic drugs 1 2.56 
Others  1 2.56 
*CNS: Central Nervous System 
 
Majority of drugs caused ADRs that affected gastrointestinal system; 
occular, cardiovascular and hematologic effects were the least 
occurred ones. Constipation caused by CCBs and diarrhoea by 
antibiotics were the main ADRs affecting gastrointestinal system. 
Banisadi et al. [19] regarding the role clinical pharmacy residents in 
increasing the ADR reporting, observed that the gastrointestinal 
system was the most frequently affected system involved in ADRs in 
an Iranian hospital.  
 
 
Fig. 2: Organ systems affected by ADRs (n=39) 
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Among the 39 ADRs observed 48.72% were of moderate severity 
and 46.16% were of major severity. Out of 224 study patients there 
were 8 drug related admissions. Steroids were the main group of 
drugs involved. One SLE (systemic lupus erythematosus) patient on 
oral Wysolone®
Adverse drug effects 
(prednisolone) for 2 to 3 years developed adverse 
effects like facial puffiness, weight gain and hyperglycemia. 
 
Table 5: Drug related hospital admissions (n=8) 
Frequency 
Steroid induced hyperglycemia/myopathy 3 
Furosemide induced hyponatremia 2 
NSAIDs induced bronchospasm 2 
Warfarin induced gum bleeding  1 
A total of 87 interventions were done in 224 patients (table 6). It 
took an average of 25-35 minutes for per intervention. 88.5% of the 
interventions were accepted by the physicians. 
 
Table 6: Types of pharmaceutical care interventions done (n=87) 
Types of interventions Frequency Percentage 
Drug choice 
a. Drug discontinuation 
b. Addition of a new drug 








a. Decreased the dose 
b. Increased the dose 







Optimization of drug administration 
a. Change of administration route 
b. Administration modalities 
(Inappropriate timing, incompatibility 






Others 9 10.34% 
 
CONCLUSION 
Clinical pharmacy services help in monitoring drug therapy and 
identifying drug related problems. This study shows that clinical 
pharmacist’s interventions are successful in identifying and 
rectifying the different types of drug related problems occurring in 
patients admitted to a general ward. As there was a greater 
acceptance of the pharmaceutical care interventions a joint effort 
between clinical pharmacists and other health care professionals 
will provide a safer system of patient care and better utilization of 
resources. Hence there is a need for clinical pharmacists in the 
general wards to improve rational drug use and to give input to the 
physicians at the time of prescribing. 
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